Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

22.39

+1.27 (6.01%)

Sep 22, 2026, 4:00 PM EDT - Market closed

Seaport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,199	-	-
Market Cap Growth	-	-	-
Enterprise Value	930	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.01	0.02	0.02
Net Debt / Equity Ratio	-0.63	-0.91	-1.01
Net Debt / EBITDA Ratio	1.87	2.48	5.82
Net Debt / FCF Ratio	3.02	2.69	10.22
Quick Ratio	17.75	17.13	27.72
Current Ratio	18.00	17.46	27.82
Return on Equity (ROE)	-	-28.08%	-
Return on Assets (ROA)	-	-18.90%	-
Return on Capital Employed (ROCE)	-33.80%	-36.10%	-17.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-151.76%	-

SEC Filings: 10-K · 10-Q